Vitamin B12 Replacement Therapy

Initial Assessment and Treatment Protocol

The American College of Nutrition recommends administering hydroxocobalamin 1 mg intramuscularly for patients with vitamin B12 deficiency due to malabsorption, with a treatment protocol that depends on the presence of neurological symptoms 1, 2
For patients with malabsorption conditions, such as pernicious anemia, ileal resection, or bariatric surgery, parenteral therapy is required 1, 2
The initial assessment should identify the cause of deficiency, including malabsorption conditions, dietary insufficiency, or drug-induced deficiency 1, 2

For patients with neurological symptoms, the loading phase consists of hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs, followed by maintenance therapy every 2 months for life 1, 2
For patients without neurological symptoms, the loading phase consists of hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance therapy every 2-3 months for life 1, 2, 3

Post-bariatric surgery patients may require modified dosing, including 1000 mcg IM monthly or 1000-2000 mcg oral daily 2
Patients with Crohn's disease and ileal involvement may require prophylactic therapy, including 1000 mcg IM every month indefinitely 1
Patients with renal dysfunction should use methylcobalamin or hydroxocobalamin instead of cyanocobalamin due to the risk of cardiovascular complications 2

The first year of treatment should include regular monitoring of serum B12, complete blood count, and homocysteine levels at 3, 6, and 12 months 2
The target homocysteine level is <10 μmol/L for optimal outcomes 2
After stabilization, annual monitoring of B12 levels and homocysteine is recommended 1, 2

The preferred formulation is hydroxocobalamin due to its longer tissue retention compared to cyanocobalamin 1, 2
The route of administration is intramuscular or deep subcutaneous injection, with preferred injection sites being the deltoid or vastus lateralis 2